Express Scripts's most recent trend suggests a bullish bias. One trading opportunity on Express Scripts is a Bull Put Spread using a strike $62.50 short put and a strike $57.50 long put offers a potential 13.38% return on risk over the next 40 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $62.50 by expiration. The full premium credit of $0.59 would be kept by the premium seller. The risk of $4.41 would be incurred if the stock dropped below the $57.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Express Scripts is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Express Scripts is bullish.
The RSI indicator is at 52.29 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Express Scripts
How These Health Care Stocks Can Benefit From Obamacare
Mon, 11 Nov 2013 16:59:59 GMT
Motley Fool – A look at the measures that CVS, Walgreen, and Express Scripts are taking to deal with changes brought on by Obamacare.
[$$] Obamacare's Impact on Pharmacy-Benefit Stocks
Thu, 07 Nov 2013 17:05:00 GMT
Barrons.com – J.P. Morgan Securities We believe recent favorable commentary on the Affordable Care Act and private exchanges should help drive improved sentiment in the pharmacy benefit management sector. We wanted …
Can CVS Continue to Outperform?
Tue, 05 Nov 2013 23:02:11 GMT
Wall St. Cheat Sheet – CVS Caremark stock has been rising higher and it is now consolidating at all time high prices.
[$$] CVS Has Rx for Profits
Tue, 05 Nov 2013 20:23:00 GMT
Barrons.com – With shares of CVS Caremark hitting a record high today, it's only natural to wonder if it's time to take some money off the table. Excluding special items, adjusted earnings per share rose to $1.05 from 85 cents, beating the $1.02 expected among analysts polled by Thomson Reuters. Granted, CVS does face some headwinds, namely Walgreen's (WAG) aggressive efforts to win back market share. While rivals are depending on acquisitions and deal making to bolster future prospects, CVS's unique business model can deliver double-digit annual profit growth over the next several years.
Second Growth Stage of Health Care IT for Hospitals: A Wall Street Transcript Interview with Charles Rhyee, a Managing Director and Senior Research Analyst Covering the Health Care Technology Sector at Cowen and Company
Mon, 04 Nov 2013 17:56:00 GMT
Wall Street Transcript – 67 WALL STREET, New York – November 4, 2013 – The Wall Street Transcript has just published its Health Care IT Report offering a timely review of the sector to serious investors and industry executives. …
Also on Market Tamer…
Follow Us on Facebook